ArticleMedicina (Kaunas, Lithuania)2023

Benefit or Risk in Patient with Type 1 Diabetes Based on Appropriated Dosage of Dapagliflozin: A Case Report.

Yan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.